USE OF MATRIX METALLOPROTEINASE-10 (MMP-10) FOR THROMBOLYTICTREATMENTS

摘要

The invention relates to the use of matrix metalloproteinase-10 (MMP-10) in the preparation of a pharmaceutical composition intended for thrombolytic therapy, which composition can also contain a plasminogen activator. In add ition, the invention relates to the aforementioned pharmaceutical compositio n for the treatment of thrombotic disorders.